{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:15:29Z","timestamp":1770905729191,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40123-026-01311-6","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:28:34Z","timestamp":1768915714000},"page":"771-780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Retrospective Review of Glueless, Sutureless Pterygium Excision Using Biovance Triple-Layer Decellularized Amniotic Basement Membrane Tissue"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5422-9748","authenticated-orcid":false,"given":"Marguerite","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"1311_CR1","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1001\/archopht.119.12.1827","volume":"119","author":"R Luthra","year":"2001","unstructured":"Luthra R, Nemesure BB, Wu SY, Xie SH, Leske MC. Frequency and risk factors for pterygium in the Barbados Eye Study. Arch Ophthalmol. 2001;119:1827\u201332.","journal-title":"Arch Ophthalmol"},{"key":"1311_CR2","first-page":"1521","volume":"127","author":"SK West","year":"2009","unstructured":"West SK, Mu\u00f1oz B. Prevalence of pterygium in a population-based study in the United States. Arch Ophthalmol. 2009;127:1521\u20135.","journal-title":"Arch Ophthalmol"},{"key":"1311_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0039-6257(02)00463-0","volume":"48","author":"LW Hirst","year":"2003","unstructured":"Hirst LW. The treatment of pterygium. Surv Ophthalmol. 2003;48:145\u201380.","journal-title":"Surv Ophthalmol"},{"key":"1311_CR4","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0161-6420(85)33831-9","volume":"92","author":"KR Kenyon","year":"1985","unstructured":"Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985;92:1461\u201370.","journal-title":"Ophthalmology"},{"key":"1311_CR5","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0161-6420(97)30197-3","volume":"104","author":"P Prabhasawat","year":"1997","unstructured":"Prabhasawat P, Barton K, Burkett G, Tseng SC. Comparison of conjunctival autografts, amniotic membrane grafts, and intraoperative mitomycin C for primary pterygium excision. Ophthalmology. 1997;104:974\u201385.","journal-title":"Ophthalmology"},{"key":"1311_CR6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/bjo.87.7.864","volume":"87","author":"LW Hirst","year":"2003","unstructured":"Hirst LW. Recurrence and complications after pterygium excision with conjunctival autograft. Br J Ophthalmol. 2003;87:864\u20135.","journal-title":"Br J Ophthalmol"},{"key":"1311_CR7","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/S0161-6420(02)01160-0","volume":"109","author":"MF Al Fayez","year":"2002","unstructured":"Al Fayez MF. Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 2002;109:1752\u20135.","journal-title":"Ophthalmology"},{"key":"1311_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0002-9394(14)72602-9","volume":"120","author":"PP Chen","year":"1995","unstructured":"Chen PP, Ariyasu RG, Kaza V, LaBree LD, McDonnell PJ. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol. 1995;120:151\u201360.","journal-title":"Am J Ophthalmol"},{"key":"1311_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/bjo.82.6.661","volume":"82","author":"JC S\u00e1nchez-Thorin","year":"1998","unstructured":"S\u00e1nchez-Thorin JC, Rocha G, Yelin JB. Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol. 1998;82:661\u20135.","journal-title":"Br J Ophthalmol"},{"key":"1311_CR10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/bjo.2003.032854","volume":"88","author":"G Koranyi","year":"2004","unstructured":"Koranyi G, Seregard S, Kopp ED. Cut and paste: a no suture, small incision approach to pterygium surgery. Br J Ophthalmol. 2004;88:911\u20134.","journal-title":"Br J Ophthalmol"},{"key":"1311_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ophtha.2004.08.028","volume":"112","author":"HS Uy","year":"2005","unstructured":"Uy HS, Reyes JM, Flores JD, Lim-Bon-Siong R. Comparison of fibrin glue and sutures for attaching conjunctival autografts after pterygium excision. Ophthalmology. 2005;112:667\u201371.","journal-title":"Ophthalmology"},{"key":"1311_CR12","first-page":"47","volume":"11","author":"Y Monden","year":"2018","unstructured":"Monden Y, Hotokezaka F, Yamakawa R. Recurrent pterygium treatment using mitomycin C, double amniotic membrane transplantation, and a large conjunctival flap. Int Med Case Rep J. 2018;11:47\u201352.","journal-title":"Int Med Case Rep J"},{"key":"1311_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/ICO.0000000000001407","volume":"37","author":"R Rosen","year":"2018","unstructured":"Rosen R. Amniotic membrane grafts to reduce pterygium recurrence. Cornea. 2018;37:189\u201393.","journal-title":"Cornea"},{"key":"1311_CR14","first-page":"165","volume":"32","author":"H Razmjoo","year":"2020","unstructured":"Razmjoo H, Abdi P, Hashemian MN, et al. Amniotic membrane transplantation in pterygium surgery: outcomes and recurrence risk factors. J Curr Ophthalmol. 2020;32:165\u201372.","journal-title":"J Curr Ophthalmol"},{"key":"1311_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4103\/joco.joco_153_20","volume":"33","author":"L Ghiasian","year":"2022","unstructured":"Ghiasian L, Samavat B, Hadi Y, Arbab M, Abolfathzadeh N. Recurrent pterygium: a review. J Curr Ophthalmol. 2022;33:367\u201378.","journal-title":"J Curr Ophthalmol"},{"key":"1311_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-025-04196-4","volume":"25","author":"SI Noguera","year":"2025","unstructured":"Noguera SI, Nicanor KSA, Ang RET, et al. Clinical outcomes of pterygium surgery over a ten-year period: a review of recurrence and complication rates. BMC Ophthalmol. 2025;25:380.","journal-title":"BMC Ophthalmol"},{"key":"1311_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4103\/ijo.IJO_824_20","volume":"69","author":"SK Kodavoor","year":"2021","unstructured":"Kodavoor SK, Preethi V, Dandapani R. Efficacy of second donor conjunctival graft from the same site for pterygium\u2014a retrospective analysis. Indian J Ophthalmol. 2021;69:559\u201362.","journal-title":"Indian J Ophthalmol"},{"key":"1311_CR18","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1136\/bjo.2006.095018","volume":"90","author":"P Luanratanakorn","year":"2006","unstructured":"Luanratanakorn P, Ratanapakorn T, Suwan-Apichon O, Chuck RS. Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision. Br J Ophthalmol. 2006;90:1476\u201380.","journal-title":"Br J Ophthalmol"},{"key":"1311_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/eye.2009.136","volume":"24","author":"C Kucukerdonmez","year":"2010","unstructured":"Kucukerdonmez C, et al. Comparison of fibrin glue and sutures for conjunctival autografting in pterygium surgery: prospective randomized trial. Eye (Lond). 2010;24:558\u201366.","journal-title":"Eye (Lond)"},{"key":"1311_CR20","first-page":"353","volume":"82","author":"SC Tseng","year":"1998","unstructured":"Tseng SC, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium. Br J Ophthalmol. 1998;82:353\u20138.","journal-title":"Br J Ophthalmol"},{"key":"1311_CR21","first-page":"2506","volume":"41","author":"N Koizumi","year":"2000","unstructured":"Koizumi N, Fullwood NJ, Bairaktaris G, Inatomi T, Kinoshita S, Quantock AJ. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci. 2000;41:2506\u201313.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1311_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1076\/0271-3683(200004)2041-5FT325","volume":"20","author":"SB Lee","year":"2000","unstructured":"Lee SB, Li DQ, Tan DT, Meller DC, Tseng SC. Suppression of TGF-beta signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Res. 2000;20:325\u201334.","journal-title":"Curr Eye Res"},{"key":"1311_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.0.CO;2-X","volume":"179","author":"SC Tseng","year":"1999","unstructured":"Tseng SC, Li DQ, Ma X. Suppression of TGF-beta signaling in human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol. 1999;179:325\u201335.","journal-title":"J Cell Physiol"},{"key":"1311_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/sj.eye.6702453","volume":"22","author":"F Memarzadeh","year":"2008","unstructured":"Memarzadeh F, Fahd AK, Shamie N, Chuck RS. Comparison of de-epithelialized amniotic membrane transplantation and conjunctival autograft after primary pterygium excision. Eye (Lond). 2008;22:107\u201312.","journal-title":"Eye (Lond)"},{"key":"1311_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/jbm.b.35186","volume":"111","author":"Y Mao","year":"2023","unstructured":"Mao Y, Protzman NM, John N, Kuehn A, Long D, Sivalenka R, et al. An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study. J Biomed Mater Res B Appl Biomater. 2023;111:684\u2013700.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"1311_CR26","first-page":"123","volume":"19","author":"K Linsey","year":"2025","unstructured":"Linsey K. Use of an eyelid pressure patch concomitantly with a decellularized dehydrated amniotic membrane for ocular surface disease management. Clin Ophthalmol. 2025;19:123\u201331.","journal-title":"Clin Ophthalmol"},{"key":"1311_CR27","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1097\/ICO.0000000000001744","volume":"37","author":"AL Young","year":"2018","unstructured":"Young AL, et al. Innovations in corneal transplantation. Cornea. 2018;37:S55\u20137.","journal-title":"Cornea"},{"key":"1311_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.2147\/OPTH.S55259","volume":"8","author":"JD Sheppard","year":"2014","unstructured":"Sheppard JD, et al. Advances in the use of amniotic membrane in dry eye disease management. Clin Ophthalmol. 2014;8:1105\u201318.","journal-title":"Clin Ophthalmol"},{"key":"1311_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1542-0124(12)70059-9","volume":"2","author":"SC Tseng","year":"2004","unstructured":"Tseng SC, et al. Amniotic membrane transplantation for ocular surface diseases. Ocul Surf. 2004;2:177\u201387.","journal-title":"Ocul Surf"},{"key":"1311_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/iwj.12140","volume":"10","author":"TJ Koob","year":"2013","unstructured":"Koob TJ, Rennert R, Zabek N, Massee M, Lim JJ, Temenoff JS, et al. Biological properties of dehydrated human amnion\/chorion composite graft: implications for chronic wound healing. Int Wound J. 2013;10:493\u2013500.","journal-title":"Int Wound J"},{"key":"1311_CR31","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.2147\/OPTH.S410452","volume":"17","author":"R Rivera-Morales","year":"2023","unstructured":"Rivera-Morales R, et al. Sutureless and glueless triple-layer dehydrated amniotic membrane for pterygium surgery: a pilot study. Clin Ophthalmol. 2023;17:2039\u201346.","journal-title":"Clin Ophthalmol"},{"key":"1311_CR32","first-page":"425","volume":"30","author":"GS Noureddin","year":"2016","unstructured":"Noureddin GS, Yeung SN. Amniotic membrane transplantation for pterygium: outcomes and patient satisfaction. Eye Lond. 2016;30:425\u201330.","journal-title":"Eye Lond"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01311-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01311-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01311-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:26:01Z","timestamp":1770902761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01311-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1311"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01311-6","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Marguerite McDonald, MD is a consultant for DefEYE, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Institutional review board (IRB) approval was obtained prior to data collection. A retrospective observational study protocol was reviewed by the IRB at Advarra (reference Pro00087862\n                      )\n                      , and the need for informed consent was determined to be exempt from IRB oversight. The IRB determined that the study met the criteria for a waiver because it was minimal risk to participants, used de-identified data, and was a retrospective study. Furthermore, the research adhered to the ethical standards outlined in the Declaration of Helsinki, ensuring compliance with guidelines for conducting research involving human participants. All patient information was de-identified to protect privacy and confidentiality.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}